Coral Snake Bite Clinical Trial
Official title:
Emergency Treatment of Coral Snake Envenomation With Antivenom
Verified date | May 2023 |
Source | University of Arizona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake. Funding Source - FDA OOPD.
Status | Completed |
Enrollment | 26 |
Est. completion date | November 11, 2016 |
Est. primary completion date | November 11, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Male or female of any age. Presenting for emergency treatment of coral snake bite. Exclusion Criteria: - Prior use of coral snake antivenom for this envenomation. Allergy to horse serum. |
Country | Name | City | State |
---|---|---|---|
United States | Florida Hospital Deland | DeLand | Florida |
United States | Lee Memorial Hospital | Fort Myers | Florida |
United States | St. Lucie Medical Center | Port Saint Lucie | Florida |
United States | Tampa General Hospital | Tampa | Florida |
United States | Banner University Medical Center | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
University of Arizona |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Who Survived | Immediately following start of infusion (day 1) through Day 22 | ||
Secondary | Change in Mean Venom Level From Baseline to 24 Hours | Through 24 hours | ||
Secondary | Change in Mean Antivenom Level From Baseline to 24 Hours | Through 24 hours |